NIH | National Cancer Institute | NCI Wiki  

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

« Previous Version 2 Current »

Date

Meeting cancelled. No data submission requests to review.

Attendees

Committee MemberPresentAbsent
Kuffel, Gina (NIH/NCI) [C]
X

Musk, Philip (NIH/NCI) [C]

X
Warren Kibbe

Kim, Erika (NIH/NCI) [E]


Gregory Tawa

William Hendriks

Matthew Breen
X
Roel Verhaak



Goals

  • Review, discuss, and prioritize ICDC study submission proposals

Outstanding Action items

Agenda

Discussion ItemWhoNotes
Study Queue

Musk, Philip (NIH/NCI) 

  • OSA04: 
    • Osteosarcoma study from Auburn University
    • 7 cases
    • Clinical and Transcriptomic data
    • Status: 
  • COTC021
    • "Evaluation of Orally Administered mTOR inhibitor Rapamycin in Dogs in the Adjuvant Setting with Osteosarcoma"
    • This is the parallel arm to COTC022: SOC in dogs with Osteosarcoma that was previously uploaded to the ICDC
    • Clinical data for 152 dogs. mRNAseq for 93 dogs
    • Status: Template-based data loading files have been received, file transfer (fastq) is complete, however md5 sums and files sizes were not provided in the requested format compatible with the ICDC system. Waiting on response from submitter.
  • UBC03
    • "Transcriptomic analyses of early stage bladder cancer in Scottish Terriers detected through screening"
    • Purdue University
    • 19 cases
    • Status: Recently met with submitters for a final review of template-based loading files. Additional edits were requested and new versions are pending from the submitter.
  • OSA02
    • "Immune Pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma"
    • Colorado State University
    • 108 cases
    • Status: Template-based loading files have been received and reviewed and there is a call set up to resolve minor issues
  • PRECINCT01 
    • "Inhaled IL-15 Immunotherapy for Treatment of Lung Metastases"
    • UC Davis
    • 21 cases
    • Status: Pathology reports and adverse event data have been indexed by DCF, the study is pending testing by the ICDC team
  • PRECINCT02
    • "Novel treatments for Diffuse large B cell lymphoma (DLBCL) in dogs"
    • Tufts University
    • 49 cases
    • Status: Updated/corrected adverse event, visit, vital signs and physical exam data received
  • PANCAN01
    • "Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds"
    • University of Georgia
    • 684 cases
    • Status: Waiting on response from submitter

Minutes (Not Verbatim)



Action items

  • No labels